{
    "Case ID": "039769",
    "Different Crime": [
        {
            "Crime Name": "unknown",
            "Crime Type": "others",
            "patent_validity": [
                "bortezomib is an obvious selection from the prior art"
            ],
            "relevant_statute": [
                "Section 28.3 of the Patent Act"
            ],
            "expert_testimony": [
                "expert evidence shows all structural elements were known or predictable"
            ],
            "infringement_analysis": [
                "bortezomib's specific structure is non-obvious"
            ],
            "decision_reasoning": [
                "choice of pyrazinecarbonyl was routine and did not add unexpected advantages"
            ],
            "result_of_case": [
                "Janssen's application was dismissed"
            ]
        }
    ]
}